生物技术公司Sionna Therapeutics今日盘中股价大涨38.89%,引发市场高度关注。
公司今日在纳斯达克交易所成功 IPO,首次公开募股规模扩大至1.91亿美元,发行价为每股18美元。然而当日开盘后,Sionna Therapeutics的股价即飙升至24美元,较发行价飙升33%,充分体现了资本市场对公司的热捧。
作为一家从事治疗囊性纤维化疾病药物研发的生物技术公司,Sionna Therapeutics正在与制药业巨头Vertex公司展开激烈竞争,力图在这一快速增长的市场占据一席之地。分析人士认为,Sionna成功 IPO体现了投资者对其长期前景的高度认可。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.